Searched for
NICHOLAS PIRAMAL
- Nicholas Piramal buys two brand groups from Khandelwal LabsDrug major Nicholas Piramal on Tuesday said it has signed a definitive agreement with Khandelwal Laboratories for purchase of Anafortan and...
- Nicholas Piramal expecting 35% growth from Baddi plantPharma major Nicholas Piramal on Saturday said that it is expecting 35 per cent growth in turnover from its Baddi plant in H.P. in the curr...
- Nicholas Piramal eyes drug cos in US, EuropeDrug major Nicholas Piramal India is on the prowl for acquisition opportunities in the US and in Europe to expand the customer base and tec...
- Nich Piramal, institutions tie up for biological drugsDrugmaker Nicholas Piramal India Ltd said on Friday its research unit has tied up with the Department of Biotechnology to identify biologic...
- Nicholas Piramal arm signs 2nd drug development deal with Eli LillyNicholas Piramal India Research & Development and Eli Lilly have signed a second new drug development agreement to develop and, in certain ...
- Nicholas Piramal undecided on strategic partner in R&D companyPharma company Nicholas Piramal to decide on partner for its new entity to be demerged from itd R&D segment.
- Nicholas Piramal, Merck in new drug discovery JVNicholas Piramal India Ltd and Merck & Co Inc have entered into a research and development agreement to discover new drugs for two selected...
- Nicholas Piramal to take oncology drug overseas aloneNicholas Piramal plans to take up oncology market on its own for its anti-blood cancer drug.
- Nicholas's NCE pipeline at Rs 1000-1300 cr: EmkayEmkay Research is positive on the developments and business of Nicholas Piramal Ltd though it has not made any formal rating on the stock.
- Nicholas Piramal mulls entering codeine productionDrug maker Nicholas Piramal plans to enter into production of narcotic codeine, used in various drugs, after its first quarter results were...
- Pfizer, Nicholas Piramal hit by codeine shortageHit by the shortage of raw material codeine, India’s highest selling drug (in value) Pfizer’s cough syrup Corex has slipped to the eighth s...
- Nicholas Piramal gets FDA okay for cancer drug trialsNicholas Piramal announced on Monday that it had received approval from the USFDA to start clinical trials on humans for its new cancer dru...
- Nicholas Piramal to invest $50 m in contract manufacturing bizDomestic pharma major Nicholas Piramal is planning to invest $50 million (or Rs 222 crore) in the next two years towards creating additiona...
- Nicholas Piramal in pact with US co NapoDomestic pharmaceutical major Nicholas Piramal India has entered into a plant screening agreement with San Francisco-based Napo Pharmaceuti...
- Nicholas Piramal consolidated net at Rs 55.5 croreBuoyed by overseas acquisitions, domestic pharma major Nicholas Piramal .
- Nicholas Piramal buys Jankharia ImagingDrug major Nicholas Piramal India Limited’s diagnostic lab chain Wellspring has bought Mumbai-based high tech imaging centre Jhankaria Imag...
- Nicholas Piramal buys out Boots CoThe acquisition follows Reckitt Benckiser's global acquisition of Alliance Boots' OTC business.
- Nicholas Piramal acquires remaining stake in JV coNicholas Piramal India Ltd on Wednesday said its group company and diagnostic laboratories chain, Wellspring, has acquired the remaining 40...
- NPIL reshuffles top deckNicholas Piramal’s recent acquisition of Pfizer’s UK facility has not suppressed its appetite for more inorganic growth.
- Nicholas Piramal to buy Pfizer's UK facilityThe UK subsidiary of NPIL has struck a deal to buy the manufacturing facility of Pfizer at Morpeth, UK, on an asset- purchase basis.
Load More- Nich Piramal, institutions tie up for biological drugs
